Clean Science and Technology Limited — Investor Meet, 06-08-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Clean Science Q1 FY27 consolidated sales hit a record INR264 crores. Standalone revenue grew 5% QoQ to INR203 crores, with strong EBITDA (43%) and PAT (36%). HALS now drives 22% of sales, de-risking from legacy products.

The company announced a strategic tie-up with Geneus Chem for advanced HALS, targeting INR300-350 crores additional revenue. A 5-year contract with Kemin for food/feed ingredients will boost volumes 20-40% immediately. Hydroquinone/catechol plants are stabilizing, and Performance Chemical 2 starts Q3 FY27. Management is confident in HALS growth and operational efficiencies despite raw material volatility.